Of note, 122/224 (54%) of group 1 enhancers were also co-occupied by FOXC1 and RUNX1 in primary AML cells (BB171) with strong binding close to genes such as KLF2, ID1, and MEF2C (Figures 4A and S5E). The gene discussed is FOXC1; the disease is acute myeloid leukemia.